Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study

Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study

Rationale & Objective: Heart failure (HF) is an important cause of morbidity and mortality among individuals with chronic kidney disease (CKD). A large body of evidence from preclinical and clinical studies implicates excess levels of fibroblast growth factor 23 (FGF23) in HF pathogenesis in...

Full description

Bibliographic Details
Main Authors: Alexander S. Leidner, Xuan Cai, Leila R. Zelnick, Jungwha Lee, Nisha Bansal, Andreas Pasch, Mayank Kansal, Jing Chen, Amanda Hyre Anderson, James H. Sondheimer, James P. Lash, Raymond R. Townsend, Alan S. Go, Harold I. Feldman, Sanjiv J. Shah, Myles Wolf, Tamara Isakova, Rupal C. Mehta, Lawrence J. Appel, MD, MPH, Jing Chen, MD, MMSc, MSc, Debbie L. Cohen, MD, Harold I. Feldman, MD, MSCE, Alan S. Go, MD, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Mahboob Rahman, MD, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, Mark L. Unruh, MD, MS
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Kidney Medicine
Subjects:
Fibroblast growth factor-23
heart failure
chronic renal insufficiency
left ventricular
dysfunction
phosphorous
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059523001413

Internet

http://www.sciencedirect.com/science/article/pii/S2590059523001413

Similar Items